Compare INVZ & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVZ | CERS |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.5M | 276.0M |
| IPO Year | N/A | 1997 |
| Metric | INVZ | CERS |
|---|---|---|
| Price | $0.94 | $2.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.10 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 4.5M | 1.6M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $48,442,000.00 | ★ $199,191,000.00 |
| Revenue This Year | $146.75 | $25.31 |
| Revenue Next Year | $53.30 | $9.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 46.09 | 13.03 |
| 52 Week Low | $0.48 | $1.12 |
| 52 Week High | $3.14 | $2.26 |
| Indicator | INVZ | CERS |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 56.10 |
| Support Level | $0.91 | $2.00 |
| Resistance Level | $1.24 | $2.21 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 6.34 | 52.22 |
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.